Today, Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced positive results from a 60-subject, open-label,…
read moreSiamab Therapeutics, Inc., a biopharmaceutical company developing novel glycan-targeted cancer therapeutics, today announced the publication of positive preclinical data…
read moreAircuity released new data showing that its clients in the life sciences industry are achieving record-setting levels of energy…
read moreCorbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced…
read moreThis week on Growing Greater we learn of rare and serious systemic autoimmune condition known as dermatomyositis. We learn…
read moreWasabi on list. Read more >>
read moreEmovi, Inc., a Canadian medical device company, announced today that they were selected to join the Canadian Technology Accelerator…
read moreWith over 250 million blind people the necessity to find a solution is urgent. eSight has been working on…
read moreCorbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic,…
read moreHoth Therapeutics, Inc., a biopharmaceutical company, today announced top line data from its Cutaneous Lupus Erythematosus (CLE) study, a…
read more